Market Cap: $755.62M
Market Cap: $755.62M

Collegium Pharmaceutical (Ticker: COLL) demonstrates a remarkable turnaround in financial health with its recent quarterly update, showcasing an 8.87% year-over-year revenue growth. This improvement m…

Collegium Pharmaceutical (Ticker: COLL) demonstrates robust growth through its latest quarterly update, showcasing substantial improvements in both revenue and profitability, much to the satisfaction…
Collegium Pharmaceutical's Growth Trajectory in Pain Management Products Collegium Pharmaceutical demonstrates a robust performance in its latest quarterly results as it capitalizes on the growing dem…
Collegium Pharmaceutical Shows Strong Q4 Performance Amidst Market Challenges Collegium Pharmaceutical reports significant growth in its fourth-quarter earnings, highlighting its strategic focus on pa…
Collegium Pharmaceutical: Navigating Analyst Perspectives Amid Market Interest Collegium Pharmaceutical is currently at the center of attention within the pharmaceutical industry, as six financial ana…
WAVE Life Sciences Prepares for Earnings Report That Could Define Its Future in Biotech As WAVE Life Sciences approaches its quarterly earnings report scheduled for November 10, 2025, anticipation mou…
Collegium Pharmaceutical's Strategic Focus on Pain Management Innovation Collegium Pharmaceutical emphasizes its commitment to addressing the pressing needs in pain management through innovative solut…
Collegium Pharmaceutical’s Strategic Positioning in the Evolving Pain Management Market Collegium Pharmaceutical is carving out a significant niche in the pain management sector with its innovative ap…
Collegium Pharmaceutical's Strategic Positioning in a Competitive Market Collegium Pharmaceutical is currently navigating a dynamic landscape within the pharmaceutical industry, marked by increasing c…
Confidence in Collegium: Insider Transaction Signals Commitment to Growth In a recent development, Gino Santini, a board member of Collegium Pharmaceutical, engages in a notable insider transaction by…
Collegium Pharmaceutical Board Member Signals Confidence Through Insider Transaction Recent insider trading activity by Gino Santini, a Board Member of Collegium Pharmaceutical, underscores the commit…
Insider Confidence: Gino Santini's Transaction Signals Commitment to Collegium Pharmaceutical's Growth In a significant development for Collegium Pharmaceutical, Gino Santini, a member of the company'…
Collegium Pharmaceutical Faces Scrutiny Over Insider Trading Activity In a recent development that raises eyebrows within the pharmaceutical sector, Dr. John G. Freund, a director at Collegium Pharmac…
Collegium Pharmaceutical: Insider Trading Sparks Industry Conversation Collegium Pharmaceutical, a key player in developing innovative therapies for pain management, is under scrutiny following an ins…
Collegium Pharmaceutical Sees Insider Trading Activity: Implications for Company Dynamics Collegium Pharmaceutical, a company dedicated to developing and commercializing innovative pain management the…
Collegium Pharmaceutical's Leadership Confidence Reflected in Insider Transaction In a significant move, Dr. John G. Freund, a director at Collegium Pharmaceutical, exercises stock options for 50,000…
Collegium Pharmaceutical Director Demonstrates Confidence with Significant Stock Option Exercise Collegium Pharmaceutical is currently experiencing a notable moment as John G. Freund, MD, a director o…
Insider Confidence Shines Through at Collegium Pharmaceutical Collegium Pharmaceutical (COLL) recently witnesses a significant insider transaction that underscores the confidence of its leadership in…
PPG Recognizes Innovators to Drive Future Growth in Coatings Industry PPG Industries, a leader in the coatings and specialty materials sector, highlights its commitment to technological advancement by…
Collegium Pharmaceutical Recognizes Technological Innovators in Coating Industry In a significant move to celebrate innovation within its ranks, PPG Industries has inducted five prominent leaders into…